Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Pediatric Transplants

Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging

Abstract

Osteonecrosis after hematopoietic SCT (HCT) has seldom been addressed in pediatric populations. At our institution, since January 2002, children undergoing allogeneic HCT (alloHCT) receive yearly follow-up magnetic resonance imaging (MR) of hips and knees. To estimate the prevalence, longitudinal changes and associated risk factors for osteonecrosis after alloHCT, we reviewed MRs for children who underwent single alloHCT during the study period. We analyzed 149 of 344 patients who had post-HCT MR imaging performed (84 males; median age 11 years (range, 0.5–21years)), median follow-up time was 32.6 months (range, 2.8–97.2 months). In all, 44 (29.5%) developed osteonecrosis of hips and/or knees; of those, 20 (45%) had at least 30% epiphyseal involvement. In 23 (52%), osteonecrosis lesions were identified in the first and in 43 (98%) by the third yearly scan. Knees were more frequently involved than hips; severity of osteonecrosis was greater in hips. Those who had pre-alloHCT osteonecrosis, two patients’ hips and six patients’ knees resolved completely; three patients’ osteonecrosis lesions regressed after alloHCT. On risk factor analysis, age at time of alloHCT (P=0.051) and osteonecrosis identified by MRs before alloHCT (P=0.001) were the primary risk factors. This analysis shows that preventive strategies for osteonecrosis in this population should focus on measures to minimize risk factors before alloHCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010; 363: 2091–2101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Socie G, Cahn JY, Carmelo J, Vernant JP, Jouet JP, Ifrah N et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Societe Francaise de Greffe de Moelle (SFGM). Br J Haematol 1997; 97: 865–870.

    Article  CAS  PubMed  Google Scholar 

  3. Enright H, Haake R, Weisdorf D . Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation. Am J Med 1990; 89: 733–738.

    Article  CAS  PubMed  Google Scholar 

  4. Kadan-Lottick NS, Dinu I, Wasilewski-Masker K, Kaste S, Meacham LR, Mahajan A et al. Osteonecrosis in adult survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol 2008; 26: 3038–3045.

    Article  PubMed  Google Scholar 

  5. Karimova EJ, Rai SN, Howard SC, Neel M, Britton L, Pui CH et al. Femoral head osteonecrosis in pediatric and young adult patients with leukemia or lymphoma. J Clin Oncol 2007; 25: 1525–1531.

    Article  PubMed  Google Scholar 

  6. Hungerford MW, Hungerford DS, Khanuja HS, Pietryak BP, Jones LC . Survivorship of femoral revision hip arthroplasty in patients with osteonecrosis. J Bone Joint Surg Am 2006; 88 (Suppl): 3126–3130.

    Google Scholar 

  7. Tauchmanova L, De Rosa G, Serio B, Fazioli F, Mainolfi C, Lombardi G et al. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation – a single center experience and a review. Cancer 2003; 97: 2453–2461.

    Article  PubMed  Google Scholar 

  8. Socie G, Selimi F, Sedel L, Frija J, Devergie A, Esperou Bourdeau H et al. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors. Br J Haematol 1994; 86: 624–628.

    Article  CAS  PubMed  Google Scholar 

  9. Schulte CM, Beelen DW . Avascular osteonecrosis after allogeneic hematopoietic stem-cell transplantation: diagnosis and gender matter. Transplantation 2004; 78: 1055–1063.

    Article  PubMed  Google Scholar 

  10. Fink JC, Leisenring WM, Sullivan KM, Sherrard DJ, Weiss NS . Avascular necrosis following bone marrow transplantation: a case-control study. Bone 1998; 22: 67–71.

    Article  CAS  PubMed  Google Scholar 

  11. Campbell S, Sun CL, Kurian S, Francisco L, Carter A, Kulkarni S et al. Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation. Cancer 2009; 115: 4127–4135.

    Article  PubMed  Google Scholar 

  12. Balduzzi A, Gooley T, Anasetti C, Sanders JE, Martin PJ, Petersdorf EW et al. Unrelated donor marrow transplantation in children. Blood 1995; 86: 3247–3256.

    CAS  PubMed  Google Scholar 

  13. Faraci M, Calevo MG, Lanino E, Caruso S, Messina C, Favr C et al. Osteonecrosis after allogeneic stem cell transplantation in childhood. A case-control study in Italy. Haematologica 2006; 91: 1096–1099.

    PubMed  Google Scholar 

  14. Kaste SC, Shidler TJ, Tong X, Srivastava DK, Rochester R, Hudson MM et al. Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation. Bone Marrow Transplant 2004; 33: 435–441.

    Article  CAS  PubMed  Google Scholar 

  15. Leung W, Ahn H, Rose SR, Phipps S, Smith T, Gan K et al. A prospective cohort study of late sequelae of pediatric allogeneic hematopoietic stem cell transplantation. Medicine (Baltimore) 2007; 86: 215–224.

    Article  Google Scholar 

  16. Mascarin M, Giavitto M, Zanazzo GA, Andolina M, Cova M, Accorsi E et al. Avascular necrosis of bone in children undergoing allogeneic bone marrow transplantation. Cancer 1991; 68: 655–659.

    Article  CAS  PubMed  Google Scholar 

  17. Wagener P, Schulte D, Link H, Kirchner H, Stoll M, Poliwoda H . Musculoskeletal manifestations in patients after bone marrow transplantation. Initial clinical rheumatologic observations. Z Rheumatol 1991; 50: 199–203.

    CAS  PubMed  Google Scholar 

  18. Atkinson K, Cohen M, Biggs J . Avascular necrosis of the femoral head secondary to corticosteroid therapy for graft-versus-host disease after marrow transplantation: effective therapy with hip arthroplasty. Bone Marrow Transplant 1987; 2: 421–426.

    CAS  PubMed  Google Scholar 

  19. Sharma S, Yang S, Rochester R, Britton L, Leung WH, Yang J et al. Prevalence of osteonecrosis and associated risk factors in children before allogeneic BMT. Bone Marrow Transplant 2011; 46: 813–819.

    Article  CAS  PubMed  Google Scholar 

  20. Karimova EJ, Rai SN, Deng X, Ingle DJ, Ralph AC, Neel MD et al. MRI of knee osteonecrosis in children with leukemia and lymphoma: part 1, observer agreement. AJR Am J Roentgenol 2006; 186: 470–476.

    Article  PubMed  Google Scholar 

  21. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    Article  PubMed  Google Scholar 

  22. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  23. Centers for Disease Control and Prevention.. CDC Criteria. 2011. Available from: www.cdc.gov/healthyweight/assessing/bmi/childrens_bmi/about_childrens_bmi.html.

  24. Zeger SL, Liang KY . Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121–130.

    Article  CAS  PubMed  Google Scholar 

  25. Flint J, Harding RM, Boyce AJ, Clegg JB . The population genetics of the haemoglobinopathies. Baillieres Clin Haematol 1998; 11: 1–51.

    Article  CAS  PubMed  Google Scholar 

  26. Marchese VG, Connolly BH, Able C, Booten AR, Bowen P, Porter BM et al. Relationships among severity of osteonecrosis, pain, range of motion, and functional mobility in children, adolescents, and young adults with acute lymphoblastic leukemia. Phys Ther 2008; 88: 341–350.

    Article  PubMed  Google Scholar 

  27. Niinimaki RA, Harila-Saari AH, Jartti AE, Seuri RM, Riikonen PV, Pääkkö EL et al. High body mass index increases the risk for osteonecrosis in children with acute lymphoblastic leukemia. J Clin Oncol 2007; 25: 1498–1504.

    Article  PubMed  Google Scholar 

  28. Ojala AE, Paakko E, Lanning FP, Lanning M . Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study. Med Pediatr Oncol 1999; 32: 11–17.

    Article  CAS  PubMed  Google Scholar 

  29. Ware HE, Brooks AP, Toye R, Berney SI . Sickle cell disease and silent avascular necrosis of the hip. J Bone Joint Surg Br 1991; 73: 947–949.

    Article  CAS  PubMed  Google Scholar 

  30. Akinyoola AL, Adediran IA, Asaleye CM . Avascular necrosis of the femoral head in sickle cell disease in Nigeria: a retrospective study. Niger Postgrad Med J 2007; 14: 217–220.

    CAS  PubMed  Google Scholar 

  31. Mattano L . The skeletal remains: porosis and necrosis of bone in the marrow transplantation setting. Pediatr Transplant 2003; 7 (Suppl): 371–375.

    Google Scholar 

  32. Mattano Jr LA, Sather HN, Trigg ME, Nachman JB . Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group. J Clin Oncol 2000; 18: 3262–3272.

    Article  PubMed  Google Scholar 

  33. Milner PF, Kraus AP, Sebes JI, Sleeper LA, Dukes KA, Embury SH et al. Sickle cell disease as a cause of osteonecrosis of the femoral head. N Engl J Med 1991; 325: 1476–1481.

    Article  CAS  PubMed  Google Scholar 

  34. Hernigou P, Habibi A, Bachir D, Galacteros F . The natural history of asymptomatic osteonecrosis of the femoral head in adults with sickle cell disease. J Bone Joint Surg Am 2006; 88: 2565–2572.

    Article  PubMed  Google Scholar 

  35. Mahadeo KM, Oyeku S, Taragin B, Rajpathak SN, Moody K, Santizo R et al. Increased prevalence of osteonecrosis of the femoral head in children and adolescents with sickle-cell disease. Am J Hematol 2011; 86: 806–808.

    Article  PubMed  Google Scholar 

  36. Gupta R, Adekile AD . MRI follow-up and natural history of avascular necrosis of the femoral head in Kuwaiti children with sickle cell disease. J Pediatr Hematol Oncol 2004; 26: 351–353.

    Article  PubMed  Google Scholar 

  37. Kerachian MA, Seguin C, Harvey EJ . Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 2009; 114: 121–128.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Kenzora JE, Glimcher MJ . Accumulative cell stress: the multifactorial etiology of idiopathic osteonecrosis. Orthop Clin North Am 1985; 16: 669–679.

    CAS  PubMed  Google Scholar 

  39. Jacobsohn DA . Acute graft-versus-host disease in children. Bone Marrow Transplant 2008; 41: 215–221.

    Article  CAS  PubMed  Google Scholar 

  40. Liu YM, Hockenberry M . Review of chronic graft-versus-host disease in children after allogeneic stem cell transplantation: nursing perspective. J Pediatr Oncol Nurs 2011; 28: 6–15.

    Article  PubMed  Google Scholar 

  41. Lu BB, Li KH . Lipoic acid prevents steroid-induced osteonecrosis in rabbits. Rheumatol Int (e-pub ahead of print; doi:10.1007/500296-011-1846-6).

  42. Neumayr LD, Aguilar C, Earles AN, Jergesen HE, Haberkern CM, Kammen BF et al. Physical therapy alone compared with core decompression and physical therapy for femoral head osteonecrosis in sickle cell disease. Results of a multicenter study at a mean of three years after treatment. J Bone Joint Surg Am 2006; 88: 2573–2582.

    Article  PubMed  Google Scholar 

  43. Pontikoglou C, Deschaseaux F, Sensebe L, Papadaki HA . Bone Marrow Mesenchymal Stem Cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev 2011; 7: 569–589.

    Article  Google Scholar 

  44. Hauzeur JP, Gangji V . Phases 1-3 clinical trials using adult stem cells in osteonecrosis and nonunion fractures. Stem Cells Int 2010; 2010: 410170.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Shirai K, Sera Y, Bulkeley W, Mehrotra M, Moussa O, LaRue AC et al. Hematopoietic stem cell origin of human fibroblasts: cell culture studies of female recipients of gender-mismatched stem cell transplantation and patients with chronic myelogenous leukemia. Exp Hematol 2009; 37: 1464–1471.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Gangji V, Toungouz M, Hauzeur JP . Stem cell therapy for osteonecrosis of the femoral head. Expert Opin Biol Ther 2005; 5: 437–442.

    Article  CAS  PubMed  Google Scholar 

  47. Cui Q, Botchwey EA . Emerging Ideas: treatment of precollapse osteonecrosis using stem cells and growth factors. Clin Orthop Relat Res 2010; 469: 2665–2669.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Song HJ, Lan BS, Cheng B, Zhang KF, Yan HW, Wang WZ et al. Peripheral blood stem cell transplantation for ischemic femoral head necrosis. Transplant Proc 2010; 42: 1862–1864.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by grant number P30 CA-21765 from the National Institutes of Health, a Center of Excellence grant from the State of Tennessee and the American Lebanese Syrian Associated Charities (ALSAC).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S C Kaste.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sharma, S., Leung, WH., Deqing, P. et al. Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging. Bone Marrow Transplant 47, 1067–1074 (2012). https://doi.org/10.1038/bmt.2011.234

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2011.234

Keywords

This article is cited by

Search

Quick links